Q1 2024 Holdings
Filed 2024-05-15 | 367 holdings | $5.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune Group Inc(REPL) | COM | 76029N106 | $6.6M | 802,984 | 0.1% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $9.9M | 723,000 | 0.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $10.3M | 1,534,345 | 0.2% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $12.0M | 579,594 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $12.2M | 1,540,000 | 0.2% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $13.6M | 800,000 | 0.2% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $14.9M | 240,187 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $15.8M | 667,000 | 0.3% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $16.1M | 2,190,408 | 0.3% |
| Guardant Health Inc(GH) | COM | 40131M109 | $16.3M | 791,735 | 0.3% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $16.7M | 348,000 | 0.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $18.2M | 1,538,461 | 0.3% |
| Insulet Corp(PODD) | COM | 45784P101 | $18.9M | 110,061 | 0.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $19.4M | 1,138,531 | 0.3% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $19.5M | 3,542,000 | 0.3% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $19.6M | 4,133,000 | 0.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.6M | 928,017 | 0.4% |
| Docgo Inc(DCGO) | COM | 256086109 | $20.6M | 5,104,387 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $21.5M | 1,258,650 | 0.4% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $21.9M | 329,000 | 0.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $23.2M | 3,639,000 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $24.5M | 1,061,592 | 0.4% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $25.0M | 2,382,102 | 0.4% |
| Inmode LTD(INMD) | SHS | M5425M103 | $25.2M | 1,166,704 | 0.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $25.4M | 4,995,000 | 0.4% |
| Conmed Corp(CNMD) | COM | 207410101 | $27.1M | 338,165 | 0.5% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $28.0M | $25,255,000 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $29.2M | 1,765,312 | 0.5% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $30.1M | 2,260,398 | 0.5% |
| Perspective Therapeutics Inc | COM | 46489V104 | $33.5M | 28,177,636 | 0.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $36.2M | 2,726,135 | 0.6% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $36.3M | 1,462,337 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $38.0M | 463,501 | 0.7% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $41.0M | 8,270,697 | 0.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $41.4M | 665,535 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $44.3M | 1,033,680 | 0.8% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $45.4M | 1,411,000 | 0.8% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $52.2M | 1,473,090 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $52.4M | 2,874,586 | 0.9% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $52.5M | 569,574 | 0.9% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $52.7M | 152,378 | 0.9% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $56.1M | 5,194,087 | 1.0% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $58.2M | 4,997,746 | 1.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $63.2M | 1,283,176 | 1.1% |
| Hillevax Inc | COM | 43157M102 | $66.6M | 4,004,231 | 1.2% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $80.7M | 5,127,270 | 1.4% |
| Surgery Partners Inc(SGRY) | COM | 86881A100 | $95.1M | 3,186,803 | 1.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $95.3M | 691,004 | 1.7% |
| Integra Lifesciences Hldgs C | NOTE 0.500% 8/1 | 457985AM1 | $98.7M | $103,215,000 | 1.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $99.6M | 3,090,073 | 1.7% |